Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Enhance MD vs Oak

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #17Desk pick
Enhance MD

The clearest tiered compounded pricing in the ranking — separate lines for sema, tirzepatide, a microdose tier, and a sema+tirz combo — with lab testing built in.

Marked down on: Compounded only — not FDA-approved

vs
Dispatch #114
Oak

Nationwide, package-based and quick to approve, at $200/mo for compounded semaglutide and $250 for tirzepatide — one flat rate at every dose. The catch is not secrecy but inconsistency: its advertising carries nine different "starting" prices and none of them is what it charges.

Marked down on: Oak's MARKETING layer publishes nine different "starting" figures — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term or billing cadence to none of them. None of the nine is what it charges: its own funnel quotes $200/mo semaglutide and $250/mo tirzepatide, one flat rate at every dose

Enhance MD takes this head-to-head with the higher Desk Score, 85/100 (B) against 71/100 (C) for Oak. Oak still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Enhance MD

85/100

B

Overall

Oak

71/100

C

Price transparency

82
45

State access

60
95

Molecule range

78
62

Onboarding speed

82
92

Support responsiveness

86
72

Licensing & trust

84
70

The spec sheet

FieldEnhance MDOak
Semaglutide$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay$250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning
Tirzepatide$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay$300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning
CoverageNot publicly listedAll 50 states
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forPatients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes.People who want nationwide package-based care and are willing to complete a long intake before learning what they will actually pay.
Desk Score85/100B71/100C

The verdict

Desk pick — Enhance MD

Enhance MD takes this head-to-head with the higher Desk Score, 85/100 (B) against 71/100 (C) for Oak. Oak still holds its ground where its strengths line up with yours.

Choose Enhance MD if…

Patients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes.

$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay sema · $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay tirz · Not publicly listed

Choose Oak if…

People who want nationwide package-based care and are willing to complete a long intake before learning what they will actually pay.

$250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning sema · $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning tirz · All 50 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Enhance MD · Oak.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.